Depression affects an estimated 350 million people worldwide and poses a major public health challenge, according to the World Health Organization. Researchers have discovered an unconventional way that serotonin is released from neurons that could play an important role in the mechanism through which antidepressant drugs work. The opensource study is published in the Journal of General Physiology.
The team, from The University of Florence, explain that serotonin is a chemical in the brain that plays a key role in regulating various emotions and behaviours. Like other neurotransmitters, which relay signals between neurons, serotonin is stored in small sacs called vesicles in the presynaptic terminal of one neuron and released into the synapse in response to neuronal firing to bind to receptors on a postsynaptic neuron. An imbalance in serotonin signaling is generally thought to contribute to depression.
Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressants that increase levels of extracellular serotonin by preventing its reuptake by neurons. The team explain that one of the main drawbacks of SSRIs is their delayed effect.
The team state that a contributing factor to the delay is thought to be that the firing of serotonergic neurons is itself suppressed by extracellular serotonin, which acts on inhibitory neuronal ‘autoreceptors’ in a process known as autoinhibition. Thus, SSRIs, which are intended to enhance serotonin signaling, may actually initially slow the therapeutic process.
The researchers show in the current study that the serotonin that mediates autoinhibition appears to be released into the extracellular space through a distinct process. Rather than being released from vesicles in response to neuronal firing in a process known as exocytosis, the current study indicates that this pool of serotonin may be supplied by simple diffusion across the cell membrane. The team surmise that a full understanding of this process might inform better strategies of modulating serotonin signaling in order to treat depression.
Source: The University of Florence
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.